Get the Stockscreener App
8.405
0.00%
0.00
Mimedx Group Inc stock is traded at $8.405, with a volume of 558.20K.
It is up +0.00% in the last 24 hours and down -1.58% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$8.405
Open:
$8.34
24h Volume:
558.20K
Relative Volume:
0.90
Market Cap:
$1.22B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
13.68
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+5.72%
1M Performance:
-1.58%
6M Performance:
+31.74%
1Y Performance:
-2.61%
1-Day Range:
$8.21
$8.43
1-Week Range:
$7.375
$8.46
52-Week Range:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1925 | 427.35M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.80 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.33 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.55 | 114.12M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.97 | 52.03M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Earnings Call: Growth Amidst Challenges - TipRanks
Cantor Fitzgerald Comments on MiMedx Group FY2025 Earnings - Defense World
Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) Target Price at $12.00 - Defense World
Northland Capmk Forecasts Higher Earnings for MiMedx Group - Defense World
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewswire
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2024 Earnings Call Transcript - Insider Monkey
When and Where to Catch MIMEDX's Latest Investor Presentation at the TD Cowen Conference - StockTitan
MiMedx Group Inc (MDXG) Q4 2024 Earnings: Revenue Surpasses Esti - GuruFocus.com
MiMedx: Q4 Earnings Snapshot - mySA
MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong - GuruFocus.com
MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MiMedx Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
MiMedx Group Reports Strong 2024 Financial Results - TipRanks
Earnings Flash (MDXG) Mimedx Group Reports Q4 Revenue $92.9M, vs. FactSet Est of $89.4M - Marketscreener.com
Earnings Flash (MDXG) Mimedx Group Reports Q4 Adjusted EPS $0.07, vs. FactSet Est of $0.07 - Marketscreener.com
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results - GlobeNewswire
Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q4 2024 Resul - GuruFocus.com
Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q4 2024 Result - Yahoo Finance
4,120 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Acquired by Van ECK Associates Corp - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
10,380 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Bought by Savant Capital LLC - Defense World
MiMedx Group, Inc. (MDXG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
MiMedx COO Ricci Whitlow sells $508,557 in company stock By Investing.com - Investing.com Australia
MiMedx COO Ricci Whitlow sells $508,557 in company stock - Investing.com India
MiMedx Group COO Sells Shares Worth Over $500K - TradingView
(MDXG) Investment Analysis and Advice - Stock Traders Daily
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers - GlobeNewswire Inc.
When (MDXG) Moves Investors should Listen - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Chicago Capital LLC - MarketBeat
Insiders At MiMedx Group Sold US$659k In Stock, Alluding To Potential Weakness - Simply Wall St
Amniotic Membrane Market Rapid Growth with a Significant CAGR - openPR
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 - GlobeNewswire
MIMEDX Q4 2024 Earnings Call: Key Financial Results Coming February 26What to Watch - StockTitan
While shareholders of MiMedx Group (NASDAQ:MDXG) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Purchased by SG Americas Securities LLC - MarketBeat
MiMedx Group (NASDAQ:MDXG) Shares Up 5.8%Time to Buy? - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Price Target from Analysts - Defense World
MiMedx Group, Inc. to Host Earnings Call - ACCESS Newswire
(MDXG) Proactive Strategies - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Acquires 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
JPMorgan Chase & Co. Buys 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Analysts Set Expectations for MiMedx Group FY2025 Earnings - Defense World
MiMedx Group, Inc.'s (NASDAQ:MDXG) one-year returns climbed after last week's 6.2% gain, institutional investors must be happy - Simply Wall St
Cantor Fitzgerald Predicts MiMedx Group FY2025 Earnings - MarketBeat
MiMedx Group Updates Investor Presentation in Recent 8-K Filing - Defense World
Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily
Barclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Barclays PLC Purchases 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Tendonitis Pipeline Insights 2024: Therapies, Clinical Trials, MOA, ROA, and Developments | MetrioPharm, MiMedX group, InGeneron, Novartis, R3 Stem Cell - Barchart
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):